News from orexigen therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 07, 2014, 07:00 ET

Orexigen Therapeutics Reports Corporate and Financial Results for the Second Quarter Ended June 30, 2014

Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced corporate and...

Jul 31, 2014, 08:00 ET

Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) will announce financial results for the second quarter 2014, on Thursday, August 7, 2014 before...

Jul 30, 2014, 08:00 ET

Orexigen Receives CHMP Day 180 List of Outstanding Issues

 Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced it has received the Day 180 List of Outstanding Issues (LOI) from the European...

Jun 13, 2014, 08:30 ET

Orexigen Therapeutics to Present at the Wells Fargo Securities 2014 Healthcare Conference

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Wells Fargo Securities...

Jun 11, 2014, 06:30 ET

Orexigen Receives Three Month Extension of FDA NB32 Review

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the United States Food and Drug Administration (FDA) has extended its...

Jun 02, 2014, 08:00 ET

Orexigen Announces June 11, 2014 PDUFA Action Date for NB32

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX), today announced that the United States Food and Drug Administration (FDA) has informed the...

May 09, 2014, 16:30 ET

Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Bank of America...

May 08, 2014, 16:01 ET

Orexigen Therapeutics Reports Corporate and Financial Results for the First Quarter Ended March 31, 2014

Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced corporate and...

May 01, 2014, 08:30 ET

Orexigen Therapeutics to Host First Quarter 2014 Financial Results Conference Call and Webcast

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, will announce...

Mar 12, 2014, 16:01 ET

Orexigen Therapeutics Reports Corporate and Financial Results for the Fourth Quarter and Year Ended December 31, 2013

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced corporate...

Mar 03, 2014, 08:30 ET

Orexigen Therapeutics to Host Full Year and Fourth Quarter 2013 Financial Results Conference Call and Webcast

Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, will...

Feb 27, 2014, 08:30 ET

Orexigen Therapeutics to Present at the 34th Annual Cowen and Co. Health Care Conference

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the 34th Annual Cowen and Co....

Feb 25, 2014, 08:00 ET

Orexigen Provides Update on Its NB32 European Marketing Authorization Application

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Company received the Day 120 List of Questions (LoQs) regarding its...

Feb 06, 2014, 08:30 ET

Orexigen Therapeutics to Present at Upcoming Investor Conferences

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will be presenting at two upcoming investor...

Jan 07, 2014, 08:00 ET

Orexigen Announces June 10, 2014 PDUFA Action Date for Contrave

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX), today announced that the United States Food and Drug Administration (FDA) considers the...

Jan 06, 2014, 16:30 ET

Orexigen Therapeutics to Present at the J.P. Morgan 2014 Healthcare Conference

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the J.P. Morgan 2014 Healthcare...

Dec 11, 2013, 08:00 ET

Orexigen Resubmits Contrave New Drug Application

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Company has resubmitted the Contrave® New Drug Application to the...

Dec 06, 2013, 10:45 ET

Orexigen Therapeutics, Inc. Announces the Closing of its Offering of $115 Million of Convertible Senior Notes

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) (the "Company"), a biopharmaceutical company focused on the treatment of obesity, today...

Dec 03, 2013, 07:12 ET

Orexigen Therapeutics, Inc. Prices Offering of $100 Million of Convertible Senior Notes

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) (the "Company"), a biopharmaceutical company focused on the treatment of obesity, today announced...

Dec 02, 2013, 07:00 ET

Orexigen Therapeutics, Inc. Proposed Offering of $100 Million of Convertible Senior Notes

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) (the "Company"), a biopharmaceutical company focused on...